RDNT
RadNet, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$60.68-2.43%
Price as of Jul 20, 2026
RDNT valuation
RadNet, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 59.49x
- P/E 2026E
- 77.51x
- P/E 2027E
- 55.89x
- P/E 2028E
- 46.27x
- P/S forward
- 2.02x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.42x
- Price / sales
- 2.23x
- Price / cash flow
- 13.65x
Enterprise value
- Enterprise value
- $6.5B
- EV / sales
- 3.04x
- EV / EBITDA
- 20.13x
- EV / EBIT
- 79.30x
- Market cap
- $4.8B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.